Patient-reported outcomes of upadacitinib versus abatacept in patients with rheumatoid arthritis and an inadequate response to biologic disease-modifying antirheumatic drugs: 12- and 24-week results…

Overview of attention for article published in Arthritis Research & Therapy, June 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (79th percentile)
Good Attention Score compared to outputs of the same age and source (65th percentile)

So far, Altmetric has seen 11 X posts from 11 X users, with an upper bound of 12,914 followers.

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 7 additional X posts.